Several studies have reported germline mutations in BRCA1, BRCA2, PALB2, CHEK2 and TP53 [62,63] and Fanconi Anemia genes in MDS-pCT patients [64]. This evidence concerns the gene TP53 and myelodysplastic syndrome.